List of questions
Does cancer immunotherapy have to be personalised?
As cancer antigens are unique to the patients tumours, immunotherapy HAS to be personalised.
How do we harness exisiting NHS expertise and resource to develop effective cancer immunotherapy that doesn't bancrupt the NHS?
The NHS has a number of BMT/HSCT facilities that provide cell based cancer treatments. These have the resources to develop cell-based cancer immunotherapy. Can we do this in Cambridge?